Why Merit Medical Systems (MMSI) Is Getting Attention Now

Merit Medical Systems (MMSI) is back in focus after a busy stretch, with third quarter results, a higher full year revenue outlook, ongoing tuck in M&A plans, and fresh WRAPSODY registry data drawing investor attention.

The recent third quarter report, the raised full-year revenue range, and fresh WRAPSODY registry data have all arrived as Merit Medical Systems trades at US$89.62, with a 7-day share price return of 3.92% and a 5-year total shareholder return of 32.12%. This suggests that momentum has been building gradually rather than in sudden spikes.

Compare Merit Medical Systems with other healthcare-focused compounders by scanning our hand-picked list of solid balance sheet and fundamentals (24 results) that have been holding their ground through recent earnings seasons.

Recent gains have followed solid earnings, higher guidance, and encouraging WRAPSODY data, which raises a simple question: Are investors now paying more for sentiment or for Merit Medical Systems’ underlying cash generation and growth profile?

Most Popular Narrative: 16% Undervalued

On the widely followed narrative, Merit Medical Systems screens as undervalued, with a fair value of about $106 against the recent $89.62 share price. This puts the focus firmly on what is driving that gap.

The current valuation implies the share price may not fully reflect this track record of margin expansion, organic growth near the top of current guidance, disciplined tuck in acquisitions, and a balance sheet that leaves room for further deals without high leverage.

See why 1 investors see Merit Medical Systems as 16% undervalued.

Result: Fair Value of $106.08 (UNDERVALUED)

Still, the story around Merit Medical Systems is not risk free. WRAPSODY reimbursement uncertainty and tariff costs are both capable of undermining the current undervaluation case.

Find out about the key risks to this Merit Medical Systems narrative.

Next Steps

If this mix of optimism and real risk around Merit Medical Systems feels finely balanced, consider taking prompt action and review the numbers for yourself by weighing up the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Merit Medical Systems?

Do not stop with Merit Medical Systems if you want a broader watchlist that can handle different market conditions and protect you from concentrating on one story.

• Target resilience first and scan a 32 resilient stocks with low risk scores that focuses on businesses with sturdier risk profiles and fewer financial red flags.
• Hunt for quality at a discount by checking a 21 high quality undiscovered gems that highlights companies with strong fundamentals that many investors may still be ignoring.
• Prioritise financial strength and filter through a 9 elite penny stocks with strong financials to see which smaller stocks also pair robust balance sheets with healthier fundamentals.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com